News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Luca Arecco: Prognostic implications of risk definitions from the monarchE and NATALEE trials
Luca Arecco/X
Apr 5, 2025, 05:36

Luca Arecco: Prognostic implications of risk definitions from the monarchE and NATALEE trials

Luca Arecco, Clinical Research Fellow at ESMO, posted on X about recent paper he and colleagues co-authored:

“Published in Journal of the National Cancer Institute (JNCI) our analysis assessing the prognosis of patients considered at high risk of recurrence according to monarchE and NATALEE trials inclusion criteria!”

“Prognostic implications of risk definitions from the monarchE and NATALEE trials.”

Authors: Luca Arecco, Eva Blondeaux, Marco Bruzzone, Grazia Arpino, Carmine De Angelis, Michelino De Laurentiis, Roberta Caputo, Alessandra Fabi, Valeria Sanna, Stefania Gori, Fabio Puglisi, Luca Boni, Simone Nardin, Irene Giannubilo, Marta Perachino, Roberto Borea, Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini, Lucia Del Mastro

Luca Arecco: Prognostic implications of risk definitions from the monarchE and NATALEE trials

 

 

cancer Carmine De Angelis Eva Blondeaux Grazia Arpino JNCI Luca Arecco Marco Bruzzone Michelino De Laurentiis monarchE trial NATALEE trial OncoDaily Oncology Roberta Caputo
Special Coverage
Blog
Apr 5, 2025, 05:36
Luca Arecco: Prognostic implications of risk definitions from the monarchE and NATALEE trials
Blog
Apr 5, 2025, 05:29
David J. Benjamin: Sexual health and reproductive toxicity from cancer therapies
Blog
Apr 5, 2025, 05:21
Cathy Eng: Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer
Blog
Apr 5, 2025, 05:18
Guillermo J. Ruiz-Argüelles: México was present in EBMT meeting in Florence
Opinion
Apr 5, 2025, 05:13
Abstract Submissions for the 22nd SIO International Conference are now open
Blog
Apr 5, 2025, 05:00
Welcoming Alastair Lamb to Barts Cancer Institute
Blog
Apr 5, 2025, 04:50
The Mark Foundation for Cancer Research's Scientific Symposium 2025
Blog
Apr 5, 2025, 02:56
Did you know ALK Positive can help you gain access to world-leading specialists - at no charge?
Blog
Apr 4, 2025, 20:41
Michael Sapienza: Colorectal Cancer Alliance is hiring a VP of Data Intelligence and Technology
Science
Apr 4, 2025, 20:29
Gaëlle Saint-Hilary: Benefit-risk assessment of ivosidenib vs. placebo in mIDH1 cholangiocarcinoma
Blog
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
Science
Apr 4, 2025, 19:52
Paolo Bossi: Immunotherapy plus cetuximab in advanced/metastatic cutaneous squamous cell carcinoma